Case Report
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 14, 2015; 21(26): 8208-8214
Published online Jul 14, 2015. doi: 10.3748/wjg.v21.i26.8208
Table 1 Characteristics of our 5 cases
Case 1Case 2Case 3Case 4Case 5
Age (yr)/sex78/Female74/Male67/Male72/Male70/Female
Serum anti-H. pylori antibodyNegativeNegativeNegativeNegativeNegative
Chronic gastritisAntral gastritis(-)(-)(-)(-)
LocationUpper/AntUpper/GreUpper/GreUpper/GreUpper/Post
Size (mm)135858
Macroscopic featureIIaIIaIIaIIbIIa
Microvascular pattern on NBI-MEIrregularIrregularRegularRegularRegular
Endoscopic diagnosisAdenocarcinomaSMTCarcinoidGA-FGAdenocarcinoma
Histological classificationtubulartubulartubulartubulartubular
DepthSM (700 μm)SM (80 μm)SM (980 μm)SM (110 μm)SM (1230 μm)
Lymphatic/venous invasion(+)/(-)(-)/(-)(-)/(-)(-)/(-)(-)/(-)
MUC2/MUC5AC/MUC6/Pepsinogen-I(-)/(-)/(+)/(+)(-)/(-)/(+)/(+)(-)/(-)/(+)/(+)(-)/(-)/(+)/(+)(-)/(-)/(+)/(+)
p53/Ki-67 labeling index(-)/Low(-)/Low(-)/Low(-)/Low(-)/Low
Table 2 Clinicopathological findings of previous and present cases
Reports[4][5,8][9][10][11][12][13]Present cases
Number of patients125 (27 lesions)1111105
Age (yr)8267 (average)595650s7164.2 (average)72.2 (average)
Sex (Male:Female)Female16:9FemaleMaleMaleFemale4:63:2
TherapyEMROperation: 3ESDEAMESDEMRpolypectomyESD
ESD or EMR: 7
ND: 15
Location (Upper:Middle:Lower)Upper23:4:0UpperUpperMiddleUpper10:0:05:0:0
Size (average, mm)1612.2 (3-42)8542ND4.37.8 (5-13)
Macroscopic feature (I:IIa:IIb:IIc:IIa + IIc)I (protrude)1:14:2:8:2IIbIIaIIa + IIcIIa10:0:0:0:00:4:1:0:0
Depth (M:SM)M6:21SMSMSMSM10:000:05
Lymphatic/venous(-)/(-)2/1(-)/(-)(-)/(-)(-)/(-)(-)/(-)0/01/0
invasion
Survival time (average, mo)ND27 (10-70)1712ND1215 (6-39)10.6 (2-20)
OutcomeNDNED: 10NEDNEDNDNEDNED: 8NED:5
ND: 15Persistence: 1
ND: 1